208259-57-8

Basic information

• Product Name: ETHYL 3,5-DIFLUOROBENZOYLFORMATE
• Synonyms: ETHYL 3,5-DIFLUOROBENZOYLFORMATE;ETHYL 3,5-DIFLUOROPHENYLGLYOXYLATE;Ethyl 3,5-difluorobenzoylforMate,96%;ethyl 2-(3,5-difluorophenyl)-2-oxoacetate;3,5-Difluoro-oxo-benzeneacetic acid ethyl ester;Benzeneacetic acid, 3,5-difluoro-α-oxo-, ethyl ester
• CAS NO: 208259-57-8
• Molecular Formula: C₁₀H₈F₂O₃
• Molecular Weight: 214.17
• Mol File: 208259-57-8.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 247.4 °C(lit.)
• Flash Point: 66 °C
• Appearance: /
• Density: 1.27 g/mL at 25 °C(lit.)
• Vapor Pressure: 0.00481mmHg at 25°C
• Refractive Index: n20/D 1.482(lit.)
• CAS DataBase Reference: ETHYL 3,5-DIFLUOROBENZOYLFORMATE(CAS DataBase Reference)
• NIST Chemistry Reference: ETHYL 3,5-DIFLUOROBENZOYLFORMATE(208259-57-8)
• EPA Substance Registry System: ETHYL 3,5-DIFLUOROBENZOYLFORMATE(208259-57-8)

Safety Data

• WGK Germany: 3
• Hazardous Substances Data: 208259-57-8(Hazardous Substances Data)

Usage

General Description

Ethyl 3,5-Difluorobenzoylformate is a specialized, fluorine-containing chemical compound. It belongs to the group known as benzoic acid and derivatives, which encompasses compounds containing a benzene ring which bears a carboxyl group. Its systematic name is ethyl 2-(3,5-difluorobenzoyl)acetate. Typically, this kind of chemicals is used in scientific research, particularly in the chemical and pharmaceutical industries. However, at the moment, specific details about its uses, properties, and safety are not widely available. As with any chemical, handling should be done taking into consideration safety guidelines to avoid potential hazards.

InChI:InChI=1/C10H8F2O3/c1-2-15-10(14)9(13)6-3-7(11)5-8(12)4-6/h3-5H,2H2,1H3

Upstream product

• 461-96-1 3,5-difluorobromobenzene 

Downstream Products

• 1185234-46-1 (S)-2-(3,5-difluorophenyl)-2-hydroxy-propionic acid ethyl ester 
• 1596278-77-1 (S)-isopropyl 2-(3,5-difluorophenyl)-2-hydroxyacetate 
• 1596279-17-2 isopropyl-2-(3,5-difluorophenyl)-2-oxoacetate 
• 1415635-28-7 C₃₀H₃₃F₂N₇O₃ 
• 1391837-88-9 ethyl 2-(3,5-difluorophenyl)-4-oxo-3,4-dihydro-2H-pyran-2-carboxylate 
• 1352130-08-5 C₁₃H₁₄BrF₂NO₂ 
• 1289642-97-2 (R,E)-ethyl 2-[(tert-butylsulfinyl)imino]-2-(3,5-difluorophenyl)acetate 
• 1289643-09-9 (R)-ethyl 2-(3,5-difluorophenyl)-2-[(R)-1,1-dimethylethylsulfinamido]acetate 
• 1233519-93-1 C₁₈H₂₇F₂NO₃Si 
• 1221966-49-9 ethyl 2-(3,5-difluorophenyl)-2-hydroxyacetate 

Relevant articles and documents

Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds

Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.